Oncology & Cancer
Test results after stem cell transplant for multiple myeloma can confuse patients and doctors about
It's a cancer of the plasma cells, which normally make an array of antibodies that protect us from infection.
Aug 10, 2017
0
1
Multiple Myeloma
Medical research
Promising new therapeutic approach for debilitating bone disease
An Australian-led research team has demonstrated a new therapeutic approach that can re-build and strengthen bone, offering hope for individuals with the debilitating bone cancer, multiple myeloma.
Jun 29, 2017
0
0
Oncology & Cancer
CAR T-Cell therapy sends multiple myeloma into lasting remission
In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of immunotherapy ? chimeric antigen receptor (CAR) T cells targeting B-cell maturation protein or ...
Jun 5, 2017
0
2
Oncology & Cancer
Scientists give tumor-fighting cells a boost in battling bone marrow cancer
Researchers from Belgium led by Prof. Dirk Elewaut of the VIB-UGent Center for Inflammation Research and the team of Prof. Vanderkerken and Prof. Menu at the Hematology and Immunology lab of the VUB uncovered a new way to ...
Jun 1, 2017
0
0
Oncology & Cancer
Combo Rx plus stem-cell tx ups PFS in multiple myeloma
(HealthDay)—Combination therapy with lenalidomide, bortezomib, and dexamethasone (RVD) plus stem-cell transplantation is associated with longer progression-free survival than RVD alone for adults with multiple myeloma, ...
Apr 7, 2017
0
2
Oncology & Cancer
Researchers identify therapy that shrinks tumors in patients with multiple myeloma
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mar 8, 2017
0
2
Oncology & Cancer
New treatments to extend life for multiple myeloma patients
Multiple myeloma is a cancer of the plasma cells that reside inside bone marrow. Plasma cells produce certain proteins that build up the immune system. In abnormal quantities, these proteins damage the body and compromise ...
Feb 10, 2017
0
6
Oncology & Cancer
Inhibition of EZH2 might be new therapy of multiple myeloma
In a study published in the scientific journal Oncotarget, researchers from Uppsala University show how the protein EZH2 affects the development of multiple myeloma, and that inhibition of EZH2 could be used as a new strategy ...
Jan 12, 2017
0
0
Oncology & Cancer
Zoledronic acid every 12 weeks noninferior in bone metastases
(HealthDay)—Use of zoledronic acid every 12 weeks does not result in increased risk of skeletal events compared with use every four weeks among patients with bone metastases due to breast cancer, prostate cancer, or multiple ...
Jan 4, 2017
0
2
Oncology & Cancer
Results of major myeloma treatment trial published
The addition of bortezomib to a standard two-drug regimen for multiple myeloma patients significantly lengthened the time before their cancer returned, and significantly lengthened their lives, according to clinical trial ...
Dec 22, 2016
0
1
